Fundz

Galecto Appoints Sherwin Sattarzadeh as Chief Operating Officer and Dr. Becker Hewes as Chief Medical Officer

PUBLIC · DMRAJan 06, 2026

Position

Chief Medical Officer

Company

Galecto

Becker Hewes
CopenhagenBiotechnologyHealthcareHealth CareMedicalTherapeutics

Description

Galecto, Inc announces the appointments of Sherwin Sattarzadeh as Chief Operating Officer and Dr Becker Hewes as Chief Medical Officer, effective January 5, 2026. Their extensive backgrounds in drug development are expected to strengthen the executive team as the company advances its clinical trials.

Company Information

Company

Galecto

Location

Copenhagen, Capital Region Of Denmark, Denmark

About

Galecto is a clinical-stage biotechnology company developing novel small-molecule therapeutics that target the core biological drivers of fibrosis, inflammation, and cancer. Founded by leading scientists and biotech executives with more than a decade of research into galectin biology and LOXL2 modulation, the company has built deep expertise in pathways central to complex and often devastating diseases. Galecto is backed by prominent investors including Novo Holdings, OrbiMed, Ysios, HBM Healthcare Investments, Sunstone Capital, M Ventures, Bristol-Myers Squibb, Maverick Ventures, Seventure, and SEED Capital.

Fundz sees it the moment Galecto changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Lori
Senior decision-maker at this company
••••••••@••••••••

See Lori's verified email →

Sylwia
Likely contact at this company
••••••••@••••••••

See Sylwia's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Galecto's next move

Learn about Strategic plan

Galecto changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.